Clinically, diabetes has been classified as either emanating from autoimmunity against the insulin-producing β cell (type 1 diabetes, T1D) or from an inability of the β cell to compensate for peripheral tissue insulin resistance (type 2 diabetes, T2D). This evidence concerns the gene INS and diabetes mellitus.